(Q42639324)

English

Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis

scientific article published on 12 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Gerd-Rüdiger Burmester

1

object named as

Gerd R Burmester

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hendrik Schulze-Koops

5

object named as

Hendrik Schulze-Koops

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Patrick Durez

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Galina Shestakova

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mark C Genovese

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yue Li

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ying A Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Steve Lewitzky

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Irina Koroleva

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Anni Agarwal Berneis

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

David M Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Wolfgang Hueber

12

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

12 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

49-55

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Emerging cell and cytokine targets in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

New insights into the functional role of the rheumatoid arthritis shared epitope

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Prognostic markers of radiographic progression in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Identification of citrullinated vimentin peptides as T cell epitopes in HLAâ DR4â positive patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV258

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEV258

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42639324&oldid=2049961082"